Preparation and characterization of a triamcinolone acetonide palmitate submicron emulsion

Asian Journal of Pharmaceutical Sciences

Volumn 5, Issue 2, 2010, Pages 61-73

  Peng, Cuilian ^a   Yan, Xiaonan ^a   Tang, Xing ^a  

^a SHENYANG PHARMACEUTICAL UNIVERSITY   (China)

Author keywords

Characterization; Formulation; Stability; Submicron emulsion; Triamcinolone acetonide palmitate

Indexed keywords

GLYCEROL; LYSOPHOSPHATIDYLCHOLINE; PHOSPHATIDYLCHOLINE; POLOXAMER; TRIAMCINOLONE ACETONIDE; TRIAMCINOLONE ACETONIDE PALMITATE; UNCLASSIFIED DRUG;

ARTICLE; AUTOCLAVE; DRUG DELIVERY SYSTEM; DRUG FORMULATION; DRUG STABILITY; DRUG SYNTHESIS; EMULSION; ENCAPSULATION; PARTICLE SIZE; PHYSICAL CHEMISTRY; ZETA POTENTIAL;

EID: 77958594028     PISSN: 18180876     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (36)

1. G. Abraham, F. Demiraj, F. R. Ungemach. Comparison of the hypothalamic-pituitary-adrenal axis susceptibility upon single-dose i.m. depot versus long-acting i.v. triamcinolone acetonide therapy: a direct pharmacokinetic correlation. J. Endocrinol, 2006, 191: 491-496.
2. Q. Ebrahem, A. Minamoto, G. Hoppe, et al. Triamcinolone acetonide inhibits IL-6- and VEGF-induced angiogenesis downstream of the IL-6 and VEGF receptors. Invest Ophthalmol Vis. Sci., 2006, 47: 4935-4941.
3. C. Bitter, K. Suter, V. Figueiredo, et al. Preservative-free triamcinolone acetonide suspension developed for intravitreal injection. J. Ocul. Pharmacol. Ther., 2008, 24: 62-69.
4. Y. Y. Han, W. Sun. An evidence-based review on the use of corticosteroids in peri-operative and critical care. Acta Anaesthesiol. Sin., 2002, 40: 71-79.
5. C. Picado, M. C. Vennera. Triamcinolone acetonide in the treatment of corticosteroid-resistant asthma: risks and benefits. Arch. Bronconeumol., 2008, 44: 324-327.
6. T. A. Bradshaw, S. P. Matusiewicz, G. K. Crompton, et al. Intravenous magnesium sulphate provides no additive benefit to standard management in acute asthma. Respir Med., 2008, 102: 143-149.
7. G. F. López, J. M. Vázquez, F. Gil, et al. Intra-articular therapy of experimental arthritis with a derivative of triamcinolone acetonide incorporated in liposomes. J. Pharm. Pharmacol., 1993, 45: 576-578.
8. A. Goundalkar, M. Mezei. Chemical modification of triamcinolone acetonide to improve liposomal encapsulation. J. Pharm. Sci., 1984, 73: 834-835.
9. M. Sznitowska, S. Janicki, E. Dabrowska, et al. Submicron emulsions as drug carriers studies on destabilization potential of various drugs. Eur. J. Pharm. Sci., 2001, 12: 175-179.
10. L. W. Dan. Evolution of parenteral lipid emulsions. Clin. Nutr. Suppl., 2005, 1: 5-7.
11. J. Muhannad, W. Bernd. The effect of oil components and homogenization conditions on the physicochemical properties and stability of parenteral fat emulsions. Int. J. Pharm., 1998, 163: 81-89.
12. J. J. Wang, K. C. Sung, O. Y. Hu, et al. Submicron lipid emulsion as a drug delivery system for nalbuphine and its prodrugs. J. Control. Release, 2006, 115: 140-149.
13. R. H. Müller, S. Heinemann. Fat emulsions for parenteral nutrition. Part I. Evaluation of microscopic and laser light scattering methods for the determination of the physical stability. Clin. Nutr., 1992, 11: 223-236.
14. A. Akkar, P. Namsolleck, M. Blaut, et al. Solubilizing poorly soluble antimycotic agents by emulsification via a solvent-free process. AAPS Pharm. Sci. Tech., 2004, 1: E24.
15. A. M. Thorn-Alquist. Parenteral use of diazepam in an emulsion formulation. a clinical study. Acta Anaesthesiologica Scand., 1977, 21: 400-404.
16. H. Suttmann, A. Doenicke, J. Kugler, et al. A new formulation of etomidate in lipid emulsion--bioavailability and venous provocation. Anaesthesist., 1989, 38: 421-423.
17. E. Liljeroth, J. Akeson. Less local pain on intravenous infusion of a new propofol emulsion. Acta Anaesthesiol Scand., 2005, 49: 246-251.
18. M. Jumaa, B. W. Muller. The effect of oil components and homogenization conditions on the physicochemical properties and stability of parenteral fat emulsions. Int. J. Pharm., 1997, 163: 81-89.
19. G. Alison. Floyd. Top ten considerations in the development of parenteral emulsions. Pharm. Sci. Technolo. Today, 1999, 2: 134-143.
20. A. Benichou, A. Aserin, N. Garti. Double emulsions stabilized with hybrids of natural polymers for entrapment and slow release of active matters. Adv. Colloid. Interface. Sci., 2004, 108-109: 29-41.
21. R. H. Müller, S. Heinemann. Fat emulsions for parenteral nutrition. I: Evaluation of microscopic and laser light scattering methods for the determination of the physical stability. Clin Nutr., 1992; 11: 223-236.
22. L. Rabinovich-Guilatt, C. Dubernet, K. Gaudin, et al. Phospholipid hydrolysis in a pharmaceutical emulsion assessed by physicochemical parameters and a new analytical method. Eur. J. Pharm. Biopharm., 2005, 61: 69-76.
23. J. Muhamud, W. M. Bernd. The effect of oil components and homogenization conditions on the physicochemical properties and stability of parenteral fat emulsions. Int. J. Pharm., 1998, 163: 81-89.
24. S. Benita, M. Y. Levy. Submicron emulsions as colloidal drug carriers for intravenous administration: comprehensive physicochemical characterization. J. Pharm. Sci., 1993, 82: 1069-1079.
25. T. Yamaguchi, K. Nishizaki, S. Itai, et al. Physicochemical characterization of parenteral lipid emulsion: determination of Hamaker constants and activation energy of coalescence. Pharm. Res., 1995, 12: 342-347.
26. T. Yamaguchi, K. Nishizaki, S. Itai, et al. Physicochemical characterization of parenteral lipid emulsion: influence of cosurfactants on flocculation and coalescence. Pharm. Res., 1995; 12: 1273-1278.
27. J. T. Rubino. The influence of charged lipids on the flocculation and coalescence of oil-in-water emulsions. I: Kinetic assessment of emulsion stability. J. Parenter Sci. Technol., 1990, 44: 210-215.
28. R. H. Müller, S. Heinemann. Fat emulsions for parenteral nutrition III: lipofundin MCT/LCT regimens for total parenteral nutrition (TPN) with low electrolyte load. Int. J. Pharm., 1994, 101: 175-189.
29. G. Chansiri, R. T. Lyons, M. V. Patel, et al. Effect of surface charge on the stability of oil/water emulsions during steam sterilization. J. Pharm. Sci., 1999, 88:454-458.
30. K. Nemec, E. Germ, M. Schulz-Siegmund, et al. The effect of nimodipine, fentanyl and remifentanil intravenous products on the stability of propofol emulsions. Pharmazie, 2009, 64: 94-97.
31. C. Washington. Stability of lipid emulsions for drug delivery. Adv. Drug Deliv. Rev., 1996. 20: 2-3, 131-145.
32. C. Washington, S. S. Davis. Ageing effects in parenteral fat emulsions: the role of fatty acids. Int. J. Pharm., 1987, 39: 33-37.
33. A. Akkar, R. H. Müller. Intravenous itraconazole emulsions produced by SolEmuls technology. Eur. J. Pharm. Biopharm., 2003, 56: 29-36.
34. R. L. Xiong, W. G. Lu, J. Li, et al. Preparation and characterization of intravenously injectable nimodipine nanosuspension. Int. J. Pharm., 2008, 350: 338-343.
35. G. Chansiri, R. T. Lyons, M. V. Patel, et al. Effect of surface charge on the stability of oil/water emulsions during steam sterilization. J. Pharm. Sci., 1999, 88: 454-458.
36. J. Wang, Y. Cui, X. Tang. Chemical stability of teniposide in aqueous and parenteral lipid emulsions. Drug Dev. Ind. Pharm., 2009, 35: 508-513.